- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03756376
The Relationship Between IRRIV and RFR Under Pathologic Conditions (IRRIV-RFR)
Study Overview
Status
Conditions
Detailed Description
Renal functional reserve (RFR) represents the capacity of the kidney to increase glomerular filtration rate (GFR) in response to certain physiological or pathological stimuli or conditions.
RFR is calculated as the difference between the measured maximum GFR achieved through a renal stress test and the baseline GFR measured in rest conditions. In clinical practice, the most common renal stress test is performed as a standardized protein loading test. Recently, in a pilot study, the investigators demonstrated a significant correlation between RFR and the intra-parenchymal renal resistive index variation (IRRIV) during an echo renal stress test in a cohort of healthy volunteers. IRRIV test has proven to be rapid, safe, bedside and easy to perform and it might represent a preliminary test in screening patients' RFR.The present pilot study is designed to explore the correlation between IRRIV and RFR under pathologic conditions.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Estimated GFR (CKD-EPI) greater than or equal to 60 mL/min/1.73 m2
- Scheduled cardiac surgery with cardiopulmonary bypass (coronary artery bypass, valve replacements, combined or other operations).
Exclusion Criteria:
- Age less than 18 years old
- Pregnancy
- Ultrasound evidence of morphological kidney abnormalities and/or renal artery stenosis
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Contrast media in the 2 days before the tests.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
IRRIV and RFR
Enrolled patients will receive IRRIV test and RFR assessment.
RFR will be evaluated through a protein loading test.
(1.2 g of protein/Kg of body weight) performed with cooked beef.
The RFR was then defined as the difference between the highest CrCl obtained after the protein load and the baseline CrCl measured on rest conditions.
Concerning the IRRIV test, a weight of 10% of the patient's body weight is applied on the abdominal wall.
RRIs is recorded in a middle interlobular artery, every minute for 10 minutes during the echo-renal stress test.
The lowest RRI reached is taken as reference (stress RRI).
The IRRIV is defined as the percentage difference between baseline RRI and stress RRI
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between IRRIV test and RFR in cardiac surgery patients
Time Frame: Change from baseline to 60 minutes
|
IRRIV test and RFR will be determined and a relationship will be assessed
|
Change from baseline to 60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concordance between IRRIV test and RFR in cardiac surgery patients
Time Frame: Change from baseline to 60 minutes
|
Concordance between presence of RFR (i.e. a RFR≥15ml/min/1.73m2)
and a positive/uncertain/negative IRRIV is evaluated.
|
Change from baseline to 60 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Claudio Ronco, Ospedale San Bortolo di Vicenza
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35/14
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Kidney Injury
-
Instituto Nacional de Cardiologia Ignacio ChavezInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranUnknownKidney Injury, Acute | Acute Renal Injury | Acute Kidney Injuries | Kidney Injuries, Acute | Acute Renal InjuriesMexico
-
Yonsei UniversityCompletedAcute Kidney Injury(Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery)Korea, Republic of
-
Hospital Civil de GuadalajaraNot yet recruitingAcute Kidney Disease | Acute Kidney Injury (AKI) | Acute Kidney Injuries
-
Sanliurfa Mehmet Akif Inan Education and Research...CompletedIn Acute Kidney InjuryTurkey (Türkiye)
-
University Hospital, GhentWithdrawn
-
Chang Gung Memorial HospitalConmed Pharmaceutical & Bio-Medical CorporationRecruitingAcute Kidney Disease | Acute Kidney Injury (AKI)Taiwan
-
Beni-Suef UniversityCairo UniversityRecruitingAKI - Acute Kidney InjuryEgypt
-
University Hospital MuensterBaxter Healthcare CorporationCompletedAcute Kidney Injury (AKI)Spain, France, United States, Turkey, Germany, Egypt, Italy, Libyan Arab Jamahiriya, Malta, North Macedonia, Palestinian Territory, occupied, Russian Federation, Saudi Arabia, Slovenia
-
Chinese PLA General HospitalBeijing Tsinghua Changgeng HospitalCompletedPostoperative Acute Kidney InjuryChina
-
Chinese PLA General HospitalCompletedPostoperative Acute Kidney InjuryChina